(Microbot Medical) Shares of Microbot Medical Inc. rose more than 71% after the company entered into a deal with Stryker Corporation for the development of a new robotic system for neurovascular uses.
Under the agreement, Microbot will integrate Stryker’s neurovascular instruments into its LIBERTY Robotic System to come up with the world’s first robotic procedural kids for application in select neurovascular procedures.
Microbot Medical Chairman and CEO Harel Gadot says the collaboration will help the company deepen its involvement in the neurovascular space, including altering perceptions on robotic surgery.
Microbot says it will continue developing the LIBERTY Robotic System independently for deployments in coronary and peripheral operations.
MBOT: NASDAQ is up +71.40%, SYK: NYSE is down -0.13%.
